Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 6034
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (132)
Results: 1-50 | Export
  1. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-02-26
    Posted: 2024-03-15
    Designated public office holders:
    • Anne Bowes, Director | Health Canada (HC)
    • Erin Campbell, Director | Innovation, Science and Economic Development Canada (ISED)
    • Paul Brogan, Market Director | Invest in Canada Hub
    • Michelle Ciesielski, Manager, Office of Patented Medicines and Liaison | Health Canada (HC)
    • David Lee, Chief Regulatory Officer | Health Canada (HC)
    Subject matters:
    • Health
      •
  2. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-01-31
    Posted: 2024-02-15
    Designated public office holders:
    • David Norris, Senior Trade Policy Officer | Global Affairs Canada (GAC)
    • Loris Mirella, Director | Global Affairs Canada (GAC)
    Subject matters:
    • Health
      •
  3. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-01-23
    Posted: 2024-02-15
    Designated public office holders:
    • Eshan Naik, Director of Policy | Health Canada (HC)
    Subject matters:
    • Health
      •
  4. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-01-23
    Posted: 2024-02-15
    Designated public office holders:
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Caroline Menard, Manager, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  5. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2024-01-23
    Posted: 2024-02-15
    Designated public office holders:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Health
      •
  6. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-18
    Posted: 2024-01-15
    Designated public office holders:
    • Abbigael Loomis , Investor Services Associate | Invest in Canada Hub
    • Paul Brogan, Market Director | Invest in Canada Hub
    Subject matters:
    • Economic Development
      •
  7. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-12-14
    Posted: 2024-01-15
    Designated public office holders:
    • Ophelia John, Senior Policy Advisor | Health Canada (HC)
    • Eshan Naik, Director of Policy, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  8. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-10-06
    Posted: 2023-11-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  9. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-08-01
    Posted: 2023-09-15
    Designated public office holders:
    • Linsey Hollett, Assistant Deputy Minister | Health Canada (HC)
    • Marie-Elisabeth Lebrun, Director | Health Canada (HC)
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    • Greg Loyst, Director General | Health Canada (HC)
    Subject matters:
    • Health
      •
  10. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-05-24
    Posted: 2023-06-15
    Designated public office holders:
    • Melissa Lantsman, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  11. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-03-09
    Posted: 2023-04-15
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Suzanne McGurn, President and CEO, CADTH | Health Canada (HC)
    • Eric Belair , Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  12. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-12-05
    Posted: 2023-01-16
    Designated public office holders:
    • Ben Martin, Member's Assistant | House of Commons
    • Kyle Seeback , Member of Parliament | House of Commons
    Subject matters:
    • International Trade
      •
  13. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-12-01
    Posted: 2023-01-16
    Designated public office holders:
    • Kasondra White, Director | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Departmental Liaison Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Samir Chhabra, Officer | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • International Trade
      •
  14. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-30
    Posted: 2022-12-15
    Designated public office holders:
    • Nicolas Lesieur, Senior Trade Policy Officer | Global Affairs Canada (GAC)
    • Clarissa Allen, Trade Policy Officer | Global Affairs Canada (GAC)
    • Loris Mirella, Director, Intellectual Property Trade | Global Affairs Canada (GAC)
    Subject matters:
    • International Trade
      •
  15. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-11-23
    Posted: 2022-12-15
    Designated public office holders:
    • Mary Ng, Minister of International Trade, Export Promotion, Small Business and Economic Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Trade
      •
  16. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  17. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-09-28
    Posted: 2022-10-15
    Designated public office holders:
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  18. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-08-25
    Posted: 2022-09-15
    Designated public office holders:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  19. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-06-28
    Posted: 2022-07-15
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
    • Intellectual Property
    • International Trade
      •
  20. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-24
    Posted: 2022-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  21. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-19
    Posted: 2022-06-15
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  22. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-16
    Posted: 2022-06-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director | Health Canada (HC)
    • Samir Khan, Director, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  23. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-07
    Posted: 2022-05-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  24. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-04
    Posted: 2022-05-16
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister of Health, Minister's Office | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy, Minister of Health, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  25. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-31
    Posted: 2022-04-16
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  26. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-29
    Posted: 2022-04-16
    Designated public office holders:
    • Michelle Boudreau, Executive Director,, Strategy Policy Branch, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
      •
  27. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-29
    Posted: 2022-04-16
    Designated public office holders:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  28. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-03-17
    Posted: 2022-04-16
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  29. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-01-27
    Posted: 2022-02-15
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  30. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-08-03
    Posted: 2021-09-15
    Designated public office holders:
    • Dylan Marando, Senior Policy Advisor, Policy and Cabinet Affairs | Prime Minister's Office (PMO)
    Subject matters:
    • Health
      •
  31. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-07-08
    Posted: 2021-08-16
    Designated public office holders:
    • Patrick Weiler, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  32. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-06-15
    Posted: 2021-07-15
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  33. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-06-10
    Posted: 2021-07-15
    Designated public office holders:
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  34. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-05-27
    Posted: 2021-06-15
    Designated public office holders:
    • Marcus Powlowski, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  35. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-02-01
    Posted: 2021-03-15
    Designated public office holders:
    • Bersabel Ephrem, Director General, Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Jacqueline Arthur, Sr Manager, Policy Development, AMR Division, Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Niyi Lawuyi, Advisor to Director General, Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  36. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2021-01-28
    Posted: 2021-02-15
    Designated public office holders:
    • Sheryl Groeneweg, Director General, Director's General Office, Manufacturing and Life Sciences Branch, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    • Boyan Gerasimov, Director of Policy, Office of the Minister, Minister of Public Services and Procurement Canada | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Health
      •
  37. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-12-16
    Posted: 2021-02-11
    Designated public office holders:
    • Jacqueline Arthur, Sr Manager, Policy Development, AMR Division, Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Niyi Lawuyi, Advisor to Director General, Director General's Office - Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Jennifer Siushansian, Public Health Advisor, Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  38. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-12-08
    Posted: 2021-02-11
    Designated public office holders:
    • Arianne Reza, Assistant Deputy Minister, Procurement, ADM - Procurement Branch, Acquisitions Program | Public Services and Procurement Canada (PSPC)
    • Roman Szumski, Senior Vice President, Sr VP's office, Vaccine Acquisition Branch | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Health
      •
  39. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-22
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  40. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-20
    Posted: 2020-11-16
    Designated public office holders:
    • Kathryn Nowers, Director of Policy at Office of the Minister of Health | Health Canada (HC)
    • Bud Sambasivam, Senior Policy Advisor, Deputy Prime Minister and Minister of Intergovernmental Affairs | Prime Minister's Office (PMO)
    • Rick Theis, Director of Policy and Cabinet Affairs | Prime Minister's Office (PMO)
    Subject matters:
    • Health
      •
  41. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-07
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  42. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-09-17
    Posted: 2020-10-09
    Designated public office holders:
    • Kathryn Nowers, Director of Policy, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  43. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-06-23
    Posted: 2020-07-14
    Designated public office holders:
    • Matthew Jeneroux, Member of Parliament, House of Commons | House of Commons
    Subject matters:
    • Health
      •
  44. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-06-05
    Posted: 2020-07-14
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
      •
  45. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-05-15
    Posted: 2020-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Research and Development
    • Health
      •
  46. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-04-16
    Posted: 2020-05-14
    Designated public office holders:
    • Greg Loyst, Director General, Policy and Regulatory Strategies, Regulatory, Operations and Enforcement Branch | Health Canada (HC)
    • Celia Lourenco, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Sheryl Groeneweg, Director General, Manufacturing and Life Sciences Branch, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    • J Patrick Stewart, Director General, Therapeutic Products Directorate, Health Products and Food Branch | Great Lakes Pilotage Authority
    • Gina Charos, Director General, Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
    • Supriya Sharma, Chief Medical Advisor, HC, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
      •
  47. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-03-06
    Posted: 2020-04-15
    Designated public office holders:
    • Steve Verheul, Assistant Deputy Minister, Trade Policy and Negotiations | Global Affairs Canada (GAC)
    Subject matters:
    • Health
    • Intellectual Property
    • Research and Development
      •
  48. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-05-29
    Posted: 2019-06-11
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
      •
  49. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-05-24
    Posted: 2019-06-14
    Designated public office holders:
    • Bill Blair, Minister of Border Security and Organized Crime Reduction, House of Commons | House of Commons
    Subject matters:
    • Health
      •
  50. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-03-11
    Posted: 2019-03-18
    Designated public office holders:
    • Michelle Kovacecvic, Assistant Deputy Minister, Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
    • Suzy Mccdonald, Associate Assistant Deputy Minister, Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
    Subject matters:
    • Health
    • Industry
      •
Date Modified: